Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines (Q39597656)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 3, 2011

Language	Label	Description	Also known as
English	Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines	scientific article published on February 3, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

endometrial cancer

1 reference

based on heuristic

inferred from title

5

object named as

Ilan Bruchim

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Zohar Attias-Geva

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Itay Bentov

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Ami Fishman

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Haim Werner

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

3 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0090825811000205?httpAccept=text/xml

1 reference

10.1016/J.YGYNO.2011.01.008

https://api.crossref.org/works/10.1016/J.YGYNO.2011.01.008

23 November 2024

https://api.elsevier.com/content/article/PII:S0090825811000205?httpAccept=text/plain

1 reference

10.1016/J.YGYNO.2011.01.008

https://api.crossref.org/works/10.1016/J.YGYNO.2011.01.008

23 November 2024

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

383-389

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Papillary carcinomas of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

The insulin-like growth factor-I receptor as an oncogene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Targeting the IGF1 axis in cancer proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin and insulin-like growth factor signalling in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Basic and clinical significance of IGF-I-induced signatures in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Increased Circulating Levels of Insulin-Like Growth Factor-I and Decreased Circulating Levels of Insulin-Like Growth Factor Binding Protein-1 in Postmenopausal Women with Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Endometrial cancer and the IGF system: a case-control study in Greece

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.01.008

7 January 2021

Clinical implications of insulin-like growth factors through the presence of their binding proteins and receptors expressed in gynecological cancers

14

1 reference

10.1016/J.YGYNO.2011.01.008

https://api.crossref.org/works/10.1016/J.YGYNO.2011.01.008

23 November 2024

Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice

21

1 reference

10.1016/J.YGYNO.2011.01.008

https://api.crossref.org/works/10.1016/J.YGYNO.2011.01.008

23 November 2024

Identifiers

10.1016/J.YGYNO.2011.01.008

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39597656&oldid=2278785502"